Antacids And Anti-ulcer (Segars) Flashcards
What is the duration of which antacids should be used for?
Used only for short-term, temporary relief of mild pain and symptoms associated with PUD/GERD
What are the low-systemic antacids?
High-systemic?
`
Aluminum-based
Calcium-based
Magnesium-based
High systemic –> Sodium-based
What is the MOA of antacids?
Combine chemically with H ions –> result in generation of common by-products
DO NOT reduce acid secretion or production
Which antacids have a rapid onset, long DOA, and good to very good acid neutralizing capacity?
Ca and Mg
This supplemental compound is a surfactant that decreases surface tension and aids in expulsion of gas
Simethicone
What is a adverse effect of Al?
What about Mg?
What about Ca?
Na?
Al-Constipation
Mg-Diarrhea
Ca-constipation
Na-Gas/flatulence (“bicarb burp”)
When should you take antacids?
Take all antacids 1-2 hrs before other medications OR 2-4 hrs after other medications
Cimetidine, famotidine, nizatidine and ranitidine are what type of anti-ulcer agent?
H2 receptor antagonists
The “-prazoles” are this type of anti-ulcer agent
PPI
Sucralfate is this type of anti-ulcer agent
Surface acting agent
Misoprostol is this type of anti-ulcer agent
PGE1 analog
What is the MOA of H2 blockers?
Reversibly inhibit H2-receptors on basolateral membrane of parietal cell
What are adverse effects of H2 blockers?
Relatively mild and infrequent but Primarily GI-related (nausea/diarrhea/constipation) and some CNS-related (Drowsiness/headache)
Rare side effects: More likely with long-term high dosing –> Cimetidine decreases testosterone binding to androgen receptor so gynecomastia in men and galactorrhea in women
What is an important drug interaction of H2 blockers? Contraindications?
Cimetidine is the PROTOTYPICAL inhibitor of several CYP450 isoenzymes
Significant renal disease and pregnancy are contraindications
What is the MOA of PPIs?
Covalently bind to sulfhydryl groups of H/K ATPase at parietal cell secretory sites, thereby inhibiting gastric acid secretion by irreversibly inhibiting functioning ‘-ase’ pumps